Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable

Modern Pathology

Volumn 16, Issue 6, 2003, Pages 537-542

  Lüttges, Jutta ^a   Beyser, Kurt ^b   Pust, Susanne ^a   Paulus, Anja ^a   Rüschoff, Josef ^b   Klöppel, Günter ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

DNA mismatch repair genes; Mudnous phenotype; Pancreatic carcinoma

Indexed keywords

DNA; MUCIN 1; MUCIN 2;

ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRADUCTAL PAPILLARY MUCINOUS CARCINOMA; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUCINOUS CARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CARRIER PROTEINS; CHILD; DNA, NEOPLASM; DNA-BINDING PROTEINS; HUMANS; MICRODISSECTION; MICROSATELLITE REPEATS; MIDDLE AGED; MUCINS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 0038795408     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000072748.65178.2F     Document Type: Article

References (31)

1. Adsay NV, Pierson C, Sarkar F, Abrams J, Weaver D, Conlon KC, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.
2. Lüttges J, Zamboni G, Longnecker D, Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-8.
3. Heinmöller E, Dietmaler W, Zirngibl H, Heinmöller P, Scaringe W, Jauch KW, et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000;157:83-92.
4. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000;156:2123-33.
5. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zuhurak M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997;57:1731-4.
6. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
7. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
8. Hanski C, Hofmeier M, Schmitt-Gräff A, Riede E, Hanski ML, Borchard F, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 1997;182: 385-91.
9. Loeb LA. Cancer cells exhibit a mutator phenotype. Adv Cancer Res 1998;72:25-56
10. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78: 1149-67.
11. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
12. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
13. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
14. Jass JR, Do KA, Simms LA, Iino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998;42:673-9.
15. Rüschoff J, Dietmaier W, Lüttges J, Seitz G, Bocker T, Zirngibl H, et al. Poorly differentiated colonic adenocarcinoma, medullary type. Clinical, phenotypic, and molecular characteristics. Am J Pathol 1997;150:1815-25.
16. Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998;152:1501-7.
17. Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 2000;156:1641-51.
18. Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998;58:4740-4.
19. Dietmaier W, Gänsbauer S, Beyser K, Renke B, Hartmann A, Rümmele P, et al. Microsatellite instability in tumor and nonneoplastic colorectal cells from hereditary nonpolyposis colorectal cancer and sporadic high microsatellite-instable tumor patients. Pathobiology 2000;68:227-31.
20. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
21. Messerini L, Vitelli F, de Vitis LR, Mori S, Calzolari A, Palmirotta R, et al. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables. J Pathol 1997;182:380-4.
22. Jass JR. Diagnosis of hereditary non-polyposis colorectal cancer. Histopathology 1998;32:491-7.
23. Gürbüz Y, Kahlke V, Klöppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch 2002;440:505-11.
24. Klöppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics of tumours of the digestive system. WHO classification of tumours. Lyon, France: IARC Press; 2000. p. 221-30.
25. Seidel G, Zahurak M, Iacobuzio-Donahue CA, Sohn TA, Adsay NV, Yeo CJ, et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms. A study of 39 cases. Am J Surg Pathol 2002;26:56-63.
26. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
27. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993;142:1534-43.
28. Chaves P, Cruz C, Lage P, Claro I, Cravo M, Leitão CN, et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000;191:355-60.
29. Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, et al. Expression of MUC1and MUC2 mucins in epithelial ovarian tumours. J Pathol 1997;183:311-7.
30. Biemer-Hüttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA, et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 2000;6:1909-16.
31. Jass JR. Mucin core proteins as differentiation markers in the gastrointestinal tract. Histopathology 2000;37:561-4.